12 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and evaluation of novel (18)F-labeled spirocyclic piperidine derivatives ass1 receptor ligands for positron emission tomography imaging.
Key Laboratory of Radiopharmaceuticals Beijing Normal University
Stereoselective synthesis of a new class of potent and selective inhibitors of human¿8,7-sterol isomerase.
Ludwig-Maximilians University
Activity-guided isolation of steroidal alkaloid antiestrogen-binding site inhibitors from Pachysandra procumbens.
University of Illinois At Chicago
Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
University of Colorado
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
The Feinberg School of Medicine of Northwestern University
New positron emission tomography (PET) radioligand for imagings-1 receptors in living subjects.
Stanford University
A new class of selective and potent 7-dehydrocholesterol reductase inhibitors.
Martin-Luther-Universit£T Halle-Wittenberg
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
University of Innsbruck
Synthesis, radiofluorination and pharmacological evaluation of a fluoromethyl spirocyclic PET tracer for centrals1 receptors and comparison with fluoroalkyl homologs.
Institute of Radiopharmacy
Synthesis and biological evaluation of novel 4-benzylpiperazine ligands for sigma-1 receptor imaging.
Key Laboratory of Radiopharmaceuticals (Beijing Normal University)